Singapore markets closed
Straits Times Index
3,394.21 +17.02 (+0.50%) Nikkei
27,382.56 +19.81 (+0.07%) Hang Seng
22,688.90 +122.12 (+0.54%) FTSE 100
7,765.15 +4.04 (+0.05%) BTC-USD
23,226.14 +118.14 (+0.51%) CMC Crypto 200
526.66 +9.65 (+1.87%)
Anavex Life Sciences Corp. (AVXL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 10.52 |
| Open | 10.52 |
| Bid | 10.59 x 800 |
| Ask | 10.70 x 1000 |
| Day's range | 10.41 - 10.69 |
| 52-week range | 7.13 - 15.24 |
| Volume | |
| Avg. volume | 2,367,160 |
| Market cap | 823.277M |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.58 |
| Earnings date | 07 Feb 2023 - 13 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 48.80 |
- Zacks
FDA Rejects Accelerated Nod to Lilly's (LLY) Alzheimer's Drug
The FDA rejects Eli Lilly's (LLY) seeking accelerated approval of a new Alzheimer's drug, donanemab, due to the limited number of patients with at least 12 months of drug exposure data.
- Motley Fool
3 Biotech Stocks Under $15 Worth a Second Look in 2023
Novavax stands out with its more traditional, protein-based COVID-19 vaccine; MannKind is making a name for itself with inhaled therapies for diabetics and patients with lung disorders; and Anavex has a promising Alzheimer's therapy.
- Motley Fool
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why
The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data.
© 2023 Yahoo. All rights reserved.
